XML 50 R35.htm IDEA: XBRL DOCUMENT v3.6.0.2
Acquisitions (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 01, 2024
Nov. 11, 2016
Mar. 09, 2016
Dec. 31, 2016
U.S. Rights to bioCorneum        
Acquisition        
Cash     $ 6,859  
Deferred consideration     434  
Contingent consideration     116  
Total     $ 7,409  
U.S. Rights to bioCorneum | Minimum        
Acquisition        
Estimated future payments due       $ 500
U.S. Rights to bioCorneum | General & administrative expense        
Acquisition        
Professional fees       200
U.S. Rights to bioCorneum | Forecast        
Acquisition        
Number of years for future royalty payments to be paid 4 years 6 months      
Tissue Expander Portfolio from SSP        
Acquisition        
Cash   $ 4,950    
Contingent consideration   1,050    
Total   6,000    
Tissue Expander Portfolio from SSP | Maximum        
Acquisition        
Estimated future payments due       $ 2,000
Tissue Expander Portfolio from SSP | General & administrative expense        
Acquisition        
Professional fees   $ 100